Fairfield, Bush & Co’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,245
| Closed | -$10.9K | – | 361 |
|
|
2023
Q4 | $10.9K | Buy |
+7,245
| New | +$10.5K | 0.01% | 297 |
|
|
2023
Q3 | – | Sell |
-7,245
| Closed | -$15.7K | – | 375 |
|
|
2023
Q2 | $15.7K | Buy |
+7,245
| New | +$11.3K | ﹤0.01% | 286 |
|
|
2022
Q3 | – | Sell |
-17,245
| Closed | -$44K | – | 348 |
|
|
2022
Q2 | $44K | Sell |
17,245
-56,405
| -77% | -$164K | 0.03% | 205 |
|
|
2022
Q1 | $253K | Sell |
73,650
-6,000
| -8% | -$21.2K | 0.13% | 112 |
|
|
2021
Q4 | $383K | Buy |
79,650
+15,000
| +23% | +$60.7K | 0.18% | 87 |
|
|
2021
Q3 | $236K | Sell |
64,650
-12,545
| -16% | -$46.7K | 0.08% | 149 |
|
|
2021
Q2 | $313K | Buy |
77,195
+60,000
| +349% | +$235K | 0.09% | 127 |
|
|
2021
Q1 | $74K | Buy |
+17,195
| New | +$82.1K | 0.02% | 162 |
|
|
2018
Q4 | – | Sell |
-15,270
| Closed | -$53K | – | 157 |
|
|
2018
Q3 | $53K | Sell |
15,270
-6,000
| -28% | -$31.9K | 0.01% | 157 |
|
|
2018
Q2 | $100K | Hold |
21,270
| – | – | 0.03% | 156 |
|
|
2018
Q1 | $67K | Sell |
21,270
-8,100
| -28% | -$32.6K | 0.02% | 167 |
|
|
2017
Q4 | $144K | Sell |
29,370
-18,750
| -39% | -$109K | 0.04% | 157 |
|
|
2017
Q3 | $330K | Sell |
48,120
-10,485
| -18% | -$66.1K | 0.1% | 111 |
|
|
2017
Q2 | $386K | Sell |
58,605
-37,000
| -39% | -$259K | 0.12% | 108 |
|
|
2017
Q1 | $765K | Sell |
95,605
-200
| -0.2% | -$1.68K | 0.24% | 68 |
|
|
2016
Q4 | $891K | Sell |
95,805
-1,273
| -1% | -$13.2K | 0.29% | 61 |
|
|
2016
Q3 | $1.03M | Sell |
97,078
-5,400
| -5% | -$53.8K | 0.33% | 55 |
|
|
2016
Q2 | $957K | Sell |
102,478
-2,135
| -2% | -$21.7K | 0.33% | 55 |
|
|
2016
Q1 | $1.09M | Buy |
104,613
+35,425
| +51% | +$324K | 0.39% | 50 |
|
|
2015
Q4 | $695K | Buy |
69,188
+6,650
| +11% | +$66.7K | 0.24% | 70 |
|
|
2015
Q3 | $526K | Sell |
62,538
-55,940
| -47% | -$740K | 0.23% | 76 |
|
|
2015
Q2 | $1.91M | Sell |
118,478
-5,165
| -4% | -$80.3K | 0.57% | 50 |
|
|
2015
Q1 | $1.75M | Buy |
123,643
+325
| +0.3% | +$4.23K | 0.51% | 54 |
|
|
2014
Q4 | $1.23M | Buy |
123,318
+5,600
| +5% | +$47.9K | 0.35% | 65 |
|
|
2014
Q3 | $1M | Buy |
117,718
+9,045
| +8% | +$79.5K | 0.29% | 77 |
|
|
2014
Q2 | $961K | Buy |
108,673
+13,550
| +14% | +$118K | 0.28% | 76 |
|
|
2014
Q1 | $886K | Buy |
95,123
+22,123
| +30% | +$194K | 0.42% | 46 |
|
|
2013
Q4 | $616K | Sell |
73,000
-1,700
| -2% | -$17.2K | 0.28% | 57 |
|
|
2013
Q3 | $658K | Buy |
+74,700
| New | +$599K | 0.2% | 88 |
|
Other funds holding OPK
RCMNY
PCM
Fairfield, Bush & Co's OPK Position: Q1 2024 in Review
Fairfield, Bush & Co sold out of Opko Health (OPK) in Q1 2024, closing a stake of 7,245 shares — an estimated $10.9K sold.
Fairfield, Bush & Co first reported a position in OPK in Q3 2013 and held it in 29 quarters. The position peaked at $1.91M in Q2 2015. 226 funds tracked by Wall St. Rank hold OPK as of Q1 2024.
- Fairfield, Bush & Co reported no remaining Opko Health position as of Q1 2024 after selling out during the quarter.
- Fairfield, Bush & Co sold 7,245 Opko Health shares in Q1 2024, an estimated $10.9K.
- Fairfield, Bush & Co first reported a position in Opko Health in Q3 2013 and held it in 29 quarters.
- Fairfield, Bush & Co's Opko Health position peaked at $1.91M in Q2 2015.
- 226 funds tracked by Wall St. Rank held Opko Health as of Q1 2024.
Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.